Cargando…

Serum CCL21 as a Potential Biomarker for Cognitive Impairment in Spinal Cord Injury

OBJECTIVE: Cognitive impairment is considered to be an important complication of spinal cord injury (SCI), but its underlying mechanism remains unclear. The purpose of this study is to explore whether serum CCL21 can be used as a potential biomarker of cognitive impairment in SCI. METHODS: In Neck-S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yuanzhen, Liang, Liangke, Cao, Shengnan, Hou, Guangjian, Zhang, Qian, Ma, Hong, Shi, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746442/ https://www.ncbi.nlm.nih.gov/pubmed/33376730 http://dx.doi.org/10.1155/2020/6692802

Ejemplares similares

Association between Serum IL-37 and Spinal Cord Injury: A Prospective Observational Study
por: Chen, Yuanzhen, et al.
Publicado: (2020)

Serum neutrophil gelatinase-associated lipocalin as a potential biomarker for cognitive decline in spinal cord injury
por: Zhang, Qinghao, et al.
Publicado: (2023)

Higher serum β2-microglobulin is a predictive biomarker for cognitive impairment in spinal cord injury
por: Cui, Zhonghao, et al.
Publicado: (2023)

Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury
por: Cao, Shengnan, et al.
Publicado: (2022)

Netrin-1: A Serum Marker Predicting Cognitive Impairment after Spinal Cord Injury
por: Meng, Yan, et al.
Publicado: (2022)

Elevated Serum Neuropeptide FF Levels Are Associated with Cognitive Decline in Patients with Spinal Cord Injury
por: Sun, Shifei, et al.
Publicado: (2021)

Nogo-A Is a Potential Prognostic Marker for Spinal Cord Injury
por: Shi, Haojun, et al.
Publicado: (2022)

Serum IL-37 Level Is Associated with Rheumatoid Arthritis and Disease Activity: A Meta-Analysis
por: Cao, Shengnan, et al.
Publicado: (2021)

Serum Irisin as a Potential Biomarker for Cognitive Decline in Vascular Dementia
por: Zhang, Feng, et al.
Publicado: (2021)

CCL3 contributes to secondary damage after spinal cord injury
por: Pelisch, Nicolas, et al.
Publicado: (2020)

CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury
por: Akimoto, N, et al.
Publicado: (2013)

Correction to: CCL3 contributes to secondary damage after spinal cord injury
por: Pelisch, Nicolas, et al.
Publicado: (2021)

Spinal cord injury-induced cognitive impairment: a narrative review
por: Alcántar-Garibay, Oscar V., et al.
Publicado: (2022)

Clinical Efficacy and Safety of “Three-Dimensional Balanced Manipulation” in the Treatment of Cervical Spondylotic Radiculopathy by Finite Element Analysis
por: Cao, Shengnan, et al.
Publicado: (2021)

Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice
por: Liu, Xin-Hua, et al.
Publicado: (2021)

The Blood Pressure Pendulum following Spinal Cord Injury: Implications for Vascular Cognitive Impairment
por: Sachdeva, Rahul, et al.
Publicado: (2019)

CCL21 Cancer Immunotherapy
por: Lin, Yuan, et al.
Publicado: (2014)

Crosstalk between Heart Failure and Cognitive Impairment via hsa-miR-933/RELB/CCL21 Pathway
por: Feng, Wenxiao, et al.
Publicado: (2021)

Delayed Imatinib Treatment for Acute Spinal Cord Injury: Functional Recovery and Serum Biomarkers
por: Kjell, Jacob, et al.
Publicado: (2015)

Brain White Matter Impairment in Patients with Spinal Cord Injury
por: Zheng, Weimin, et al.
Publicado: (2017)

CCL28 promotes locomotor recovery after spinal cord injury via recruiting regulatory T cells
por: Wang, Pengfei, et al.
Publicado: (2019)

Multifunctional biomimetic spinal cord: New approach to repair spinal cord injuries
por: Liu, Yang, et al.
Publicado: (2017)

The Prognostic Value of Leucine-Rich α2 Glycoprotein 1 in Pediatric Spinal Cord Injury
por: Ma, Hong, et al.
Publicado: (2021)

CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
por: Akhavanpoor, Mohammadreza, et al.
Publicado: (2014)

Identification of Serum Metabolites as Prognostic Biomarkers Following Spinal Cord Injury: A Pilot Study
por: Bykowski, Elani A., et al.
Publicado: (2023)

Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury
por: Zhou, Yue, et al.
Publicado: (2018)

Recruitment of γδ T cells to the lesion via the CCL2/CCR2 signaling after spinal cord injury
por: Xu, Ping, et al.
Publicado: (2021)

Macrophage migration inhibitory factor facilitates astrocytic production of the CCL2 chemokine following spinal cord injury
por: Zhang, Han, et al.
Publicado: (2022)

Revascularization After Traumatic Spinal Cord Injury
por: Yao, Chun, et al.
Publicado: (2021)

Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment
por: Chen, Bowen, et al.
Publicado: (2020)

Parallel Metabolomic Profiling of Cerebrospinal Fluid, Plasma, and Spinal Cord to Identify Biomarkers for Spinal Cord Injury
por: Yang, Hua, et al.
Publicado: (2021)

Cognitive and Emotional Empathy in Individuals with Spinal Cord Injury
por: Guadagni, Veronica, et al.
Publicado: (2019)

Cognition and Quality of Life of People with Spinal Cord Injury
por: Houldsworth, Ceri, et al.
Publicado: (2023)

The Correlation of Serums CCL11, CCL17, CCL26, and CCL27 and Disease Severity in Patients with Urticaria
por: Lu, Tao, et al.
Publicado: (2016)

Human immune cells infiltrate the spinal cord and impair recovery after spinal cord injury in humanized mice
por: Carpenter, Randall S., et al.
Publicado: (2019)

Revisiting CCL-type chemokines in breast cancer and its milieu: prominent targetable chemokines, CCL8 and CCL21
por: Unver, Nese
Publicado: (2021)

The protective effect of microRNA-21 in neurons after spinal cord injury
por: Zhang, Tao, et al.
Publicado: (2018)

Targeting miR-21 in spinal cord injuries: a game-changer?
por: Malvandi, Amir Mohammad, et al.
Publicado: (2022)

Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic pain
por: Biber, Knut, et al.
Publicado: (2014)

Differential ligand-signaling network of CCL19/CCL21-CCR7 system
por: Raju, Rajesh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pcngsnag5s0gmcbkc4dd592vbk